Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Jul 30;29(10):2019–2025. doi: 10.1158/1055-9965.EPI-20-0569

Table 4.

Associations (HR and 95% CI)a between hormone-related factors and EOC risk by race/ethnicity.

Overallb White African American Native Hawaiian Japanese American Latina Pintc
Number of cases/total number 607/91,625 155/21,742 93/17,870 57/6,789 161/25,028 141/20,196
Parity
 Nulliparous (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Parous 0.72 (0.58, 0.89) 0.70 (0.47, 1.03) 0.82 (0.46, 1.45) 0.77 (0.33, 1.84) 0.64 (0.43, 0.94) 0.82 (0.47, 1.44) 0.89d
 1 child 0.82 (0.61, 1.12) 1.01 (0.60, 1.71) 0.54 (0.23, 1.25) 0.43 (0.09, 2.16) 0.85 (0.49, 1.46) 0.96 (0.43, 2.11)
 2 children 0.78 (0.60, 1.01) 0.67 (0.41, 1.07) 0.93 (0.46, 1.84) 0.84 (0.29, 2.39) 0.72 (0.46, 1.12) 1.00 (0.51, 1.96)
 3 children 0.74 (0.56, 0.97) 0.55 (0.33, 0.94) 1.20 (0.61, 2.36) 0.83 (0.30, 2.27) 0.59 (0.36, 0.96) 1.00 (0.53, 1.91)
 ≥4 children 0.62 (0.48, 0.81) 0.69 (0.43, 1.12) 0.66 (0.34, 1.27) 0.80 (0.32, 1.96) 0.45 (0.26, 0.79) 0.71 (0.40, 1.28) 0.43e
 ptrend number of children (incl. 0) <0.01 0.08 0.64 0.78 <0.01 0.02
 ptrend number of children (excl. 0) 0.01 0.34 0.92 0.49 0.03 0.01
Age at menarche
 <13 years (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 13-14 years 0.83 (0.70, 0.99) 0.98 (0.70, 1.39) 0.72 (0.45, 1.15) 0.86 (0.48, 1.55) 0.74 (0.52, 1.05) 0.84 (0.59, 1.21)
 ≥15 years 1.01 (0.79, 1.29) 1.50 (0.95, 2.39) 0.81 (0.42, 1.56) 0.92 (0.39, 2.21) 0.98 (0.62, 1.55) 0.80 (0.48, 1.35) 0.89
Age at natural menopausef
 <45 years (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 45-49 years 1.04 (0.75, 1.44) 0.96 (0.52, 1.76) 1.56 (0.60, 4.03) 0.72 (0.22, 2.36) 0.91 (0.47, 1.74) 1.03 (0.53, 1.99)
 50-54 years 1.10 (0.80, 1.51) 0.83 (0.46, 1.52) 1.88 (0.75, 4.69) 1.66 (0.61, 4.56) 0.84 (0.45, 1.55) 1.16 (0.61, 2.20)
 ≥55 years 1.25 (0.84, 1.86) 1.00 (0.47, 2.16) 0.76 (0.19, 3.09) 0.67 (0.13, 3.54) 0.99 (0.47, 2.07) 2.60 (1.24, 5.42) 0.18
Cumulative ovulatory yearsg
 Tertile 1 (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Tertile 2 1.06 (0.81, 1.38) 1.18 (0.72, 1.94) 1.04 (0.48, 2.23) 2.14 (0.84, 5.46) 0.74 (0.44, 1.23) 0.98 (0.55, 1.74)
 Tertile 3 1.27 (0.96, 1.67) 1.25 (0.73, 2.13) 1.39 (0.63, 3.04) 2.57 (0.95, 6.96) 0.80 (0.48, 1.33) 1.64 (0.93, 2.91) 0.37
 Ptrend 0.01 0.25 0.31 0.09 0.64 0.08
OC use
 Never (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Ever 0.77 (0.63, 0.94) 1.13 (0.78, 1.66) 0.77 (0.46, 1.30) 0.62 (0.33, 1.17) 0.60 (0.39, 0.93) 0.69 (0.46, 1.04) 0.67h
 Ever <5 years 0.91 (0.73, 1.13) 1.43 (0.96, 2.14) 0.88 (0.49, 1.56) 0.76 (0.39, 1.50) 0.75 (0.47, 1.18) 0.71 (0.45, 1.13)
 Ever ≥5 years 0.54 (0.39, 0.73) 0.66 (0.38, 1.14) 0.66 (0.32, 1.35) 0.38 (0.13, 1.11) 0.35 (0.16, 0.78) 0.65 (0.34, 1.25) 0.63i
PMH usej
 Never (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Ever 1.08 (0.91, 1.29) 0.92 (0.65, 1.31) 0.82 (0.51, 1.30) 0.92 (0.50, 1.69) 1.21 (0.86, 1.70) 1.46 (1.02, 2.10) 0.25h
 Ever <5 years 1.05 (0.86, 1.29) 0.82 (0.54, 1.26) 0.85 (0.51, 1.42) 0.97 (0.50, 1.87) 1.30 (0.88, 1.91) 1.31 (0.87, 1.98)
 Ever ≥5 years 1.16 (0.91, 1.48) 1.04 (0.68, 1.59) 0.59 (0.24, 1.48) 0.83 (0.29, 2.40) 1.11 (0.70, 1.76) 2.13 (1.30, 3.49) 0.18i
Hysterectomyk
 No (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Yes 1.02 (0.83, 1.25) 1.09 (0.73, 1.62) 1.16 (0.74, 1.83) 1.13 (0.60, 2.13) 0.77 (0.48, 1.24) 1.00 (0.67, 1.52) 0.73
BMI
 <25 kg/m2 (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 25-29.9 kg/m2 0.77 (0.63, 0.94) 0.83 (0.56, 1.21) 0.81 (0.46, 1.43) 0.48 (0.24, 0.95) 0.87 (0.59, 1.27) 0.75 (0.50, 1.13)
 ≥30 kg/m2 1.12 (0.90, 1.39) 1.12 (0.74, 1.70) 1.37 (0.81, 2.29) 0.76 (0.42, 1.40) 1.03 (0.54, 1.97) 1.10 (0.73, 1.66) 0.94
 ptrend 0.16 0.23 0.52 0.64 0.82 0.40
Diabetes
 No (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Yes 1.12 (0.86, 1.45) 0.98 (0.46, 2.10) 1.38 (0.80, 2.39) 1.70 (0.87, 3.30) 0.72 (0.38, 1.36) 1.16 (0.72, 1.85) 0.40
Smoking status
 Never (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Ever 1.07 (0.90,1.26) 1.08 (0.79, 1.49) 0.86 (0.57, 1.30) 0.77 (0.45, 1.29) 1.20 (0.86, 1.68) 1.25 (0.88, 1.77) 0.42
Family history of breast and/or ovarian cancer
 No (ref.) 1.00 1.00 1.00 1.00 1.00 1.00
 Yes 1.19 (0.96, 1.48) 1.08 (0.71, 1.65) 1.08 (0.62, 1.90) 0.82 (0.38, 1.73) 1.36 (0.90, 2.05) 1.48 (0.95, 2.31) 0.63
a

Cox proportional hazards models adjusted for baseline age (continuous), menopausal status (pre-/peri- [ref.], postmenopausal), use of OCs (never [ref.], ever), and number of children (0 [ref.], 1, 2, 3, ≥4)

b

Models in the full cohort additionally adjusted for race/ethnicity (White [ref.], African American, Native Hawaiian, Japanese American, Latina)

c

Pinteraction comparing models without to models with interaction terms for the exposure and race/ethnicity variables using log-likelihood ratio tests

d

parity (no, yes)

e

number of children (0, 1, 2, 3, =>4)

f

among 51,164 postmenopausal women with a natural menopause

g

among 63,107 women with available information

h

never vs ever use

i

duration of use (never, <5, ≥5 years)

j

among 75,768 postmenopausal women

k

additionally adjusted for ever PMH use (if postmenopausal; never [ref], ever). Abbreviations: 95% CI: 95% confidence interval, BMI: body mass index, EOC: epithelial ovarian cancer; HR: hazard ratio, OC: oral contraceptive, PMH: postmenopausal hormone therapy.